IP Library Granted Patent US 12,083,087
Granted Patent B2
US 12,083,087 · App. 17/867,370 · Granted Sep 10, 2024

Aqueous formulation comprising paracetamol and ibuprofen

Inventor: Thomas Jacobsen (Liège, BE)
Assignee: Hyloris Pharmaceuticals SA
A61K31/192A61J1/10A61J1/2093A61K9/0019A61K9/08A61K31/167A61K47/20A61K47/26A61M5/1407A61M5/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,083,087
App. No.
17/867,370
Granted
Sep 10, 2024
Kind
B2
Abstract

An aqueous ibuprofen and paracetamol composition has a pH 6.3-7.3. The composition can be used as a medicament, especially for the treatment of pain and/or inflammation. The composition can be formulated for intravenous injection.

Claims (8)

1. A method for treating pain comprising intravenously administering an aqueous analgesic composition comprising 2.8-3.2 mg/ml ibuprofen and 9.8-10.2 mg/ml paracetamol, wherein the aqueous analgesic composition has a pH at the time of preparation (t 0 ) that is between 6.3 and 6.8, inclusive and wherein the ibuprofen and the paracetamol remain in solution for at least 6 months at 25±2° C. and 40±5% relative humidity.

2. The method of claim 1 , wherein the pH of the aqueous analgesic composition six months after the time of preparation is no higher than 7.3.

3. The method of claim 1 , wherein the aqueous analgesic composition comprises an isotonic agent.

4. The method of claim 1 , wherein the isotonic agent is mannitol.

5. The method of claim 1 , wherein the aqueous analgesic composition comprises cysteine.

6. The method of claim 1 , wherein the aqueous analgesic composition has dissolved oxygen content below 2 ppm.

7. The method of claim 1 , wherein after one year of storage at 25±2° C. and 40±5% relative humidity, the aqueous analgesic composition comprises less than 0.05% wt/wt 4-aminophenol and less than 0.05% wt/wt 4-nitrophenol.

8. The method of claim 1 , wherein the aqueous analgesic composition comprises 3 mg/ml ibuprofen and 10 mg/ml paracetamol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2022
From: JACOBSEN, THOMAS
To: EVERBRIGHT S.A.R.L.
Reel/Frame 060805/0829 →
CHANGE OF NAME Recorded Aug 15, 2022
From: EVERBRIGHT S.A.R.L.
To: HYLORIS PHARMACEUTICALS SA
Reel/Frame 061175/0396 →
Priority Claims (1)
WO PCT/EP2014/065544 · Jul 18, 2014 · international
Continuity (4)
Continuation 17502899 · Oct 15, 2021
Continuation 16424274 · May 28, 2019
Division 15326958
Related Publication 20230181502A1 · Jun 15, 2023